Cagent Vascular, Inc. announced that the first patient was enrolled in the Serranator OCT study. The study will use intravascular ...

First, they said the current rates for heart procedures are very low and need to be urgently revised. Second, they have demanded a full-time cardiothoracic vascular surgeon (CTVS) be made available ...

These issues are include- (i) need for urgent review and revision of the current rates of cardiac procedures to make them sustainable, (ii) requirement of a full-time on-site cardiothoracic vascular ...

As of 8:11:15 a.m. GMT+2. Market Open.

In some cases, you may be called for an interview to aid in the selection process. You will be informed of the outcome of your application in October/ November for admission in January the following ...